265 related articles for article (PubMed ID: 25515005)
1. On optimal treatment regimes selection for mean survival time.
Geng Y; Zhang HH; Lu W
Stat Med; 2015 Mar; 34(7):1169-84. PubMed ID: 25515005
[TBL] [Abstract][Full Text] [Related]
2. On Estimation of Optimal Treatment Regimes For Maximizing
Jiang R; Lu W; Song R; Davidian M
J R Stat Soc Series B Stat Methodol; 2017 Sep; 79(4):1165-1185. PubMed ID: 28983189
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dynamic treatment regimes via inverse probability weighting.
Hernán MA; Lanoy E; Costagliola D; Robins JM
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
[TBL] [Abstract][Full Text] [Related]
4. Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.
Laber EB; Zhao YQ; Regh T; Davidian M; Tsiatis A; Stanford JB; Zeng D; Song R; Kosorok MR
Stat Med; 2016 Apr; 35(8):1245-56. PubMed ID: 26506890
[TBL] [Abstract][Full Text] [Related]
5. Demystifying optimal dynamic treatment regimes.
Moodie EE; Richardson TS; Stephens DA
Biometrics; 2007 Jun; 63(2):447-55. PubMed ID: 17688497
[TBL] [Abstract][Full Text] [Related]
6. Subgroup analysis with semiparametric models toward precision medicine.
Yuan A; Chen X; Zhou Y; Tan MT
Stat Med; 2018 May; 37(11):1830-1845. PubMed ID: 29575056
[TBL] [Abstract][Full Text] [Related]
7. Estimation in optimal treatment regimes based on mean residual lifetimes with right-censored data.
Liu Z; Zhan Z; Lin C; Zhang B
Biom J; 2023 Dec; 65(8):e2200340. PubMed ID: 37789592
[TBL] [Abstract][Full Text] [Related]
8. DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.
Jiang R; Lu W; Song R; Hudgens MG; Naprvavnik S
Ann Appl Stat; 2017 Sep; 11(3):1763-1786. PubMed ID: 29308102
[TBL] [Abstract][Full Text] [Related]
9. Using decision lists to construct interpretable and parsimonious treatment regimes.
Zhang Y; Laber EB; Tsiatis A; Davidian M
Biometrics; 2015 Dec; 71(4):895-904. PubMed ID: 26193819
[TBL] [Abstract][Full Text] [Related]
10. Bayesian inference for optimal dynamic treatment regimes in practice.
Rodriguez Duque D; Moodie EEM; Stephens DA
Int J Biostat; 2023 Nov; 19(2):309-331. PubMed ID: 37192544
[TBL] [Abstract][Full Text] [Related]
11. Model assessment in dynamic treatment regimen estimation via double robustness.
Wallace MP; Moodie EE; Stephens DA
Biometrics; 2016 Sep; 72(3):855-64. PubMed ID: 26756122
[TBL] [Abstract][Full Text] [Related]
12. Sample size planning for survival prediction with focus on high-dimensional data.
Götte H; Zwiener I
Stat Med; 2013 Feb; 32(5):787-807. PubMed ID: 22859340
[TBL] [Abstract][Full Text] [Related]
13. Assessing temporal agreement between central and local progression-free survival times.
Zeng D; Cornea E; Dong J; Pan J; Ibrahim JG
Stat Med; 2015 Feb; 34(5):844-58. PubMed ID: 25393731
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
Dagne GA
J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
[TBL] [Abstract][Full Text] [Related]
15. Quantile-Optimal Treatment Regimes.
Wang L; Zhou Y; Song R; Sherwood B
J Am Stat Assoc; 2018; 113(523):1243-1254. PubMed ID: 30416233
[TBL] [Abstract][Full Text] [Related]
16. Model validation and selection for personalized medicine using dynamic-weighted ordinary least squares.
Wallace MP; Moodie EE; Stephens DA
Stat Methods Med Res; 2017 Aug; 26(4):1641-1653. PubMed ID: 28486872
[TBL] [Abstract][Full Text] [Related]
17. Analysing survival in the presence of an auxiliary variable.
Finkelstein DM; Schoenfeld DA
Stat Med; 1994 Sep; 13(17):1747-54. PubMed ID: 7997708
[TBL] [Abstract][Full Text] [Related]
18. Nonparametric estimation of the mean function of a stochastic process with missing observations.
Hu XJ; Lagakos SW
Lifetime Data Anal; 2007 Mar; 13(1):51-73. PubMed ID: 17195105
[TBL] [Abstract][Full Text] [Related]
19. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
Cho Y; Ghosh D
PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
[TBL] [Abstract][Full Text] [Related]
20. Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint.
Brückner M; Titman A; Jaki T
Stat Med; 2017 Sep; 36(20):3137-3153. PubMed ID: 28612371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
